PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

Peli BioThermal Announces Second Successive Queen’s Award Win!

Logo for The Queen’s Awards for Enterprise: International Trade 2010

Award granted for international export expertise
Peli BioThermal, the global name in temperature controlled packaging, announces it has won the Queen’s Award for Enterprise: International Trade 2018.  The company is celebrating its second consecutive Queen’s Award win, adding the accolade to last year’s award for innovation for its Chronos™ Advance.

The distinguished honour was awarded for Peli BioThermal’s export expertise; providing the global life sciences industry with thermal protection packaging solutions for the safe transportation of pharmaceuticals.  Overseas sales have grown significantly, by 122%, over the past three years and 61% of sales is exported for the company based in Leighton Buzzard, Bedfordshire.

Peli BioThermal President David Williams said: “We are proud to receive this auspicious award again, this time for International Trade.  It is an absolute honour to receive Royal recognition for our outstanding performance exporting our pioneering products worldwide.”

CEO of corporate parent, Pelican Products, Lyndon Faulkner, added: “I am thrilled that Pelican is receiving the Queen’s Award for a second year in a row. It is an extraordinary accomplishment and recognizes Pelican’s steadfast commitment to delivering quality products and services to our customers around the world.”

The Queen’s Awards for Enterprise are the United Kingdom’s most accomplished business awards, which recognise and celebrate enterprise excellence.

The judging panel highlighted how the company’s “introduction of a reusable and rental product range, offers significant customer return on investment and the ability to obtain and use products at short notice, but without investing large sums of money upfront. Major markets include Benelux, Central America and the Far East. Overseas sales have grown by 122% over the last three years and 61% of sales is exported. The company wins the Queen’s Award for International Trade for Outstanding Short Term Growth in overseas sales over the last three years.”

Members of the Peli BioThermal leadership team will be among the winners attending a reception at Buckingham Palace later this year. To learn more about the wide range of Peli BioThermal globally-available products, visit http://pelibiothermal.com.

Peli BioThermal is a division of Peli Products, S.L.U., which is the European arm of Pelican Products, Inc., a portfolio company of Behrman Capital, a private equity investment firm based in New York and San Francisco.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026